NEW YORK, Nov. 03, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning,
Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of OncoSec Medical
Incorporated (NASDAQ:ONCS), Synchrony Financial (NYSE:SYF), DaVita Inc. (NYSE:DVA), Capital One Financial Corporation (NYSE:COF),
TransEnterix, Inc. (NYSE:TRXC), and Hess Corporation (NYSE:HES) including updated fundamental summaries, consolidated fiscal
reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
ONCS DOWNLOAD: http://Fundamental-Markets.com/register/?so=ONCS
SYF DOWNLOAD: http://Fundamental-Markets.com/register/?so=SYF
DVA DOWNLOAD: http://Fundamental-Markets.com/register/?so=DVA
COF DOWNLOAD: http://Fundamental-Markets.com/register/?so=COF
TRXC DOWNLOAD: http://Fundamental-Markets.com/register/?so=TRXC
HES DOWNLOAD: http://Fundamental-Markets.com/register/?so=HES
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine
OncoSec Medical Incorporated (NASDAQ:ONCS), Synchrony Financial (NYSE:SYF), DaVita Inc. (NYSE:DVA), Capital One Financial
Corporation (NYSE:COF), TransEnterix, Inc. (NYSE:TRXC), and Hess Corporation (NYSE:HES) on a fundamental level and outlines the
overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion,
and overall direction going forward. Several excerpts from the recently released reports are available to today’s readers
below.
Important Notice: the following excerpts are not designed to be standalone
summaries and as such, important information may be missing from these samples. All information in this
release was accessed November 2, 2017. Please download the entire research report, free of charge, to ensure you are reading all
relevant material information. All amounts in millions (except per share amounts).
ONCOSEC MEDICAL INCORPORATED (ONCS) REPORT OVERVIEW
OncoSec Medical's Recent Financial
Performance
For the three months ended April 30, 2017 vs April 30, 2016, OncoSec Medical reported diluted earnings per share
-$0.22 vs -$0.37. For the twelve months ended July 31, 2016 vs July 31, 2015, OncoSec Medical reported diluted earnings per share
-$1.63 vs -$1.67. OncoSec Medical is expected to report earnings on 12/14/2017. The report will be for the fiscal Quarter ending
October 2017. The reported EPS for the same quarter last year was -$0.29.
To read the full OncoSec Medical Incorporated (ONCS) report, download it here: http://Fundamental-Markets.com/register/?so=ONCS
SYNCHRONY FINANCIAL (SYF) REPORT OVERVIEW
Synchrony's Recent Financial Performance
For the three months ended September 30, 2017 vs September 30, 2016, Synchrony reported interest income of
$4,233 vs $3,796 (up 11.5%), diluted earnings per share $0.70 vs $0.73 (down 4.1%). For the twelve months ended December 31, 2016
vs December 31, 2015, Synchrony reported interest income of $14,778 vs $13,228 (up 11.7%), diluted earnings per share $2.71 vs
$2.65 (up 2.3%).
To read the full Synchrony Financial (SYF) report, download it here: http://Fundamental-Markets.com/register/?so=SYF
DAVITA INC. (DVA) REPORT OVERVIEW
DaVita's Recent Financial Performance
For the three months ended June 30, 2017 vs June 30, 2016, DaVita reported revenue of $3,877 vs $3,718 (up
4.3%), diluted earnings per share $0.65 vs $0.26 (up 150%). For the twelve months ended December 31, 2016 vs December 31, 2015,
DaVita reported revenue of $14,745 vs $13,782 (up 7.0%), diluted earnings per share $4.29 vs $1.25 (up 243.2%). DaVita is expected
to report earnings on 11/07/2017. The report will be for the fiscal Quarter ending September 2017. According to Zacks Investment
Research, based on 7 analysts' forecasts, the consensus EPS forecast for the quarter is $0.94. The reported EPS for the same
quarter last year was $0.95.
To read the full DaVita Inc. (DVA) report, download it here: http://Fundamental-Markets.com/register/?so=DVA
CAPITAL ONE FINANCIAL CORPORATION (COF) REPORT OVERVIEW
Capital One's Recent Financial Performance
For the three months ended June 30, 2017 vs June 30, 2016, Capital One reported revenue of $6,704 vs $6,254 (up
7.2%), diluted earnings per share $1.94 vs $1.69 (up 14.8%), and dividends per share $0.40 vs $0.40 (unchanged). For the twelve
months ended December 31, 2016 vs December 31, 2015, Capital One reported revenue of $25,501 vs $23,413 (up 8.9%), diluted earnings
per share $6.89 vs $7.07 (down 2.5%), and dividends per share $1.60 vs $1.50 (up 6.7%).
To read the full Capital One Financial Corporation (COF) report, download it here: http://Fundamental-Markets.com/register/?so=COF
TRANSENTERIX, INC. (TRXC) REPORT OVERVIEW
TransEnterix's Recent Financial Performance
For the three months ended June 30, 2017 vs June 30, 2016, TransEnterix reported revenue of $1.6 vs $0.00,
diluted earnings per share -$0.11 vs -$0.70. For the twelve months ended December 31, 2016 vs December 31, 2015, TransEnterix
reported revenue of $1.5 vs $0.00, diluted earnings per share -$1.07 vs -$0.59. TransEnterix is expected to report earnings on
11/09/2017. The report will be for the fiscal Quarter ending September 2017. According to Zacks Investment Research, based on 2
analysts' forecasts, the consensus EPS forecast for the quarter is -$0.09. The reported EPS for the same quarter last year was
-$0.11.
To read the full TransEnterix, Inc. (TRXC) report, download it here: http://Fundamental-Markets.com/register/?so=TRXC
HESS CORPORATION (HES) REPORT OVERVIEW
Hess' Recent Financial Performance
For the three months ended June 30, 2017 vs June 30, 2016, Hess reported revenue of $1,228 vs $1,269 (down
3.2%), diluted earnings per share -$1.46 vs -$1.29, and dividends per share $0.25 vs $0.25 (unchanged). For the twelve months ended
December 31, 2016 vs December 31, 2015, Hess reported revenue of $4,844 vs $6,561 (down 26.2%), diluted earnings per share -$19.92
vs -$10.78, and dividends per share $1.00 vs $1.00 (unchanged).
To read the full Hess Corporation (HES) report, download it here: http://Fundamental-Markets.com/register/?so=HES
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world’s leading
brokerages for over a decade—and continue to be one of the best information sources for investors and investment professionals
worldwide. Fundamental Markets’ roster boasts decades of financial experience and includes top financial writers, FINRA®
BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst®
(CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets’ oversight and audit staff are registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets’ roster includes
qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers.
Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit
firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries
regarding this release should be directed to Fundamental Markets’ Compliance department by Phone, at +1 667-401-0010, or by E-mail
at compliance@fundamental-markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental
Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result
from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the
material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the
publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm,
investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full
disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: andrew.duffie@fundamental-markets.com
© 2017 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a
partner network manager at partnership@fundamental-markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory
Authority, Inc.
